Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605491658 | ||
| 003 | CHVBK | ||
| 005 | 20210128100511.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20151001xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10147-015-0812-9 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10147-015-0812-9 | ||
| 245 | 0 | 0 | |a Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population |h [Elektronische Daten] |c [Yasunobu Hashimoto, Toshio Takagi, Tsunenori Kondo, Junpei Iizuka, Hirohito Kobayashi, Kenji Omae, Kazuhiko Yoshida, Kazunari Tanabe] |
| 520 | 3 | |a Objective: We compared the clinical features and prognosis of renal cell carcinoma (RCC) between patients on hemodialysis (RCC-HD) and those in the general population (RCC-general). Methods: We included a total of 1,794 patients who underwent surgery (RCC-HD, 408; RCC-general, 1,386) and analyzed the clinical characteristics and oncological outcomes using a stage-for-stage analysis between the two groups. Results: In the RCC-HD group, the mean duration of dialysis before surgery was 120months. Compared to the RCC-general group, the RCC-HD group tended to be younger (55 vs. 60years, p<0.0001) and more predominately male (84% vs. 70%, p<0.0001), and the tumor size was smaller in this group (39 vs. 49mm, p<0.0001). The pathological characteristics of the RCC-HD group included a higher frequency of papillary tumors (22% vs. 5%, p<0.0001) and stage I tumors (82% vs. 68%, p<0.0001). During the follow-up period, 39 of patients (10%) in the RCC-HD group and 193 patients (14%) in the RCC-general group died of cancer. The patients on hemodialysis had better cancer-specific survival (CSS) than their counterparts (p=0.0292) in the univariable analysis, but no significance was found in the multivariable analysis. In the stage-for-stage analysis, the 5-year CSS was similar between the two groups for each stage. Conclusions: CSS appeared to be better in the RCC-HD group than in the RCC-general group, which may be associated with the higher incidence of stage I disease in the RCC-HD group. The comparable CSS between the groups in the stage-for-stage analysis supports this finding. | |
| 540 | |a Japan Society of Clinical Oncology, 2015 | ||
| 690 | 7 | |a Kidney neoplasm |2 nationallicence | |
| 690 | 7 | |a Prognosis |2 nationallicence | |
| 690 | 7 | |a Nephrectomy |2 nationallicence | |
| 690 | 7 | |a Hemodialysis |2 nationallicence | |
| 690 | 7 | |a RCC : Renal cell carcinoma |2 nationallicence | |
| 690 | 7 | |a ESRD : End-stage renal disease |2 nationallicence | |
| 690 | 7 | |a HD : Hemodialysis |2 nationallicence | |
| 690 | 7 | |a CSS : Cancer-specific survival |2 nationallicence | |
| 690 | 7 | |a ACDK : Acquired cystic disease of kidney |2 nationallicence | |
| 700 | 1 | |a Hashimoto |D Yasunobu |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | |
| 700 | 1 | |a Takagi |D Toshio |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | |
| 700 | 1 | |a Kondo |D Tsunenori |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | |
| 700 | 1 | |a Iizuka |D Junpei |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | |
| 700 | 1 | |a Kobayashi |D Hirohito |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | |
| 700 | 1 | |a Omae |D Kenji |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | |
| 700 | 1 | |a Yoshida |D Kazuhiko |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | |
| 700 | 1 | |a Tanabe |D Kazunari |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | |
| 773 | 0 | |t International Journal of Clinical Oncology |d Springer Japan |g 20/5(2015-10-01), 1035-1041 |x 1341-9625 |q 20:5<1035 |1 2015 |2 20 |o 10147 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10147-015-0812-9 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10147-015-0812-9 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Hashimoto |D Yasunobu |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Takagi |D Toshio |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kondo |D Tsunenori |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Iizuka |D Junpei |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kobayashi |D Hirohito |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Omae |D Kenji |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Yoshida |D Kazuhiko |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Tanabe |D Kazunari |u Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, 162-8666, Tokyo, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t International Journal of Clinical Oncology |d Springer Japan |g 20/5(2015-10-01), 1035-1041 |x 1341-9625 |q 20:5<1035 |1 2015 |2 20 |o 10147 | ||